4
Changes in Ownership
REGENERON PHARMACEUTICALS, INC. Filed Acc 0001968202-24-000100
EVP Commercial sold 1,138 shares at $980.16 ($1,115,422)
- EVP Commercial acquired 1,138 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
McCourt Marion · EVP Commercial
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2024-06-03 | Exercise or conversion : show line 1 in the form 10b5-1 | +1,138 | $372.46 | $423,859 | 14,069 | D |
| 2024-06-03 | Sale : show line 2 in the form 10b5-1 | −1,138 | $980.16 | $1,115,422 | 12,931 | D |
| Open-market sales · 1,138 sh · avg $980.16 · $1,115,422 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2024-06-03 | Exercise or conversion : show line 3 in the form 10b5-1 Non-Qualified Stock Option (right to buy) | −1,138 | 2,274 | D |
Loading xslF345X05/edgardoc.xml…